au.\*:("MACDOUGALL, I. C")
Results 1 to 25 of 36
Selection :
How to get the best out of r-HuEPOMACDOUGALL, I. C.Nephrology, dialysis, transplantation (Print). 1995, Vol 10, pp 85-91, issn 0931-0509, SUP2Conference Paper
Meeting the challenges of a new millennium : optimizing the use of recombinant human erythropoietinMACDOUGALL, I. C.Nephrology, dialysis, transplantation (Print). 1998, Vol 13, pp 23-27, issn 0931-0509, SUP2Conference Paper
Poor response to erythropoietin : practical guidelines on investigation and managementMACDOUGALL, I. C.Nephrology, dialysis, transplantation (Print). 1995, Vol 10, Num 5, pp 607-614, issn 0931-0509Conference Paper
Successful treatment of acute D-lactate encephalopathy by haemodialysisHINGORANI, A. D; MACDOUGALL, I. C; BROWNE, M et al.Nephrology, dialysis, transplantation (Print). 1993, Vol 8, Num 11, pp 1283-1285, issn 0931-0509Conference Paper
Detection of functional iron deficiency during erythropoietin treatment : a new approachMACDOUGALL, I. C; CAVILL, I; HULME, B et al.BMJ. British medical journal (International ed.). 1992, Vol 304, Num 6821, pp 225-226, issn 0959-8146Article
The ventilatory cost of exercise compared in chronic heart failure and chronic renal anaemiaLEWIS, N. P; MACDOUGALL, I. C; WILLIS, N et al.Quarterly journal of medicine. 1992, Vol 83, Num 303, pp 523-531, issn 0033-5622Article
Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysisMACDOUGALL, I. C; NEUBERT, P; COLES, G. A et al.Lancet (British edition). 1989, Num 8635, pp 425-427, issn 0140-6736Article
Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenouslyMACDOUGALL, I. C; HUTTON, R. D; CAVILL, I et al.British medical journal (1857). 1989, Vol 298, Num 6692, pp 157-158, issn 0007-1447Article
OPTA-therapy with iron and erythropoiesis-stimulating agents in chronic kidney diseaseHÖRL, W. H; MACDOUGALL, I. C; ROSSERT, J et al.Nephrology, dialysis, transplantation (Print). 2007, Vol 22, issn 0931-0509, iii2-iii6, SUP3Article
Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patientsMACDOUGALL, I. C; GRAY, S. J; ELSTON, O et al.Journal of the American Society of Nephrology. 1999, Vol 10, Num 11, pp 2392-2395, issn 1046-6673Article
Treatment of progressive renal failure and nephrotic syndrome with azathioprine and prednisoloneBAKER, L. R. I; TUCKER, B; MACDOUGALL, I. C et al.Postgraduate medical journal. 1997, Vol 73, Num 864, pp 647-648, issn 0032-5473Article
Identification of auto-transplanted parathyroid tissue by Tc-99m methoxy isobutyl isonitrile scintigraphyLIGHTOWLER, C; CARROLL, M. J; CHESSER, A. M. S et al.Nephrology, dialysis, transplantation (Print). 1995, Vol 10, Num 8, pp 1372-1375, issn 0931-0509Article
A randomized controlled study of iron supplementation in patients treated with erythropoietinMACDOUGALL, I. C; TUCKER, B; THOMPSON, J et al.Kidney international. 1996, Vol 50, Num 5, pp 1694-1699, issn 0085-2538Conference Paper
Coagulation studies and fistula blood flow during erythropoietin therapy in haemodialysis patientsMACDOUGALL, I. C; DAVIES, M. E; HALLETT, I et al.Nephrology, dialysis, transplantation (Print). 1991, Vol 6, Num 11, pp 862-867, issn 0931-0509Conference Paper
Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietinMACDOUGALL, I. C; LEWIS, N. P; SAUNDERS, M. J et al.Lancet (British edition). 1990, Vol 335, Num 8688, pp 489-493, issn 0140-6736Article
Interstitial nephritis and primary biliary cirrhosis: a new association!MACDOUGALL, I. C; ISLES, C. G; WHITWORTH, J. A et al.Clinical nephrology. 1987, Vol 27, Num 1, pp 36-40, issn 0301-0430Article
Acute intermittent porphyria and chronic renal failureMARSDEN, J. T; CHOWDHURY, P; WANG, J et al.Clinical nephrology. 2008, Vol 69, Num 5, pp 339-346, issn 0301-0430, 8 p.Article
Management of iron deficiency in renal anemia : guidelines for the optimal therapeutic approach in erythropoietin-treated patientsDRÜEKE, T. B; BARANY, P; CAZZOLA, M et al.Clinical nephrology. 1997, Vol 48, Num 1, pp 1-8, issn 0301-0430Article
Technetium-99m methoxy isobutyl isonitrile (MIBI) imaging of the parathyroid glands in patients with renal failureCHESSER, A. M. S; CARROLL, M. C; LIGHTOWLER, C et al.Nephrology, dialysis, transplantation (Print). 1997, Vol 12, Num 1, pp 97-100, issn 0931-0509Article
Prostate-specific antigen levels in patients receiving long-term dialysisHARPER, L; MCINTYRE, C. W; MACDOUGALL, I. C et al.British journal of urology (Print). 1995, Vol 76, Num 4, pp 482-483, issn 0007-1331Article
Improvement in anaemia following renal transplantation but not after erythropoietin therapy in a patient with sickle-cell diseaseTHURAISINGHAM, R. C; ROGER, S. D; MACDOUGALL, I. C et al.Nephrology, dialysis, transplantation (Print). 1993, Vol 8, Num 4, pp 371-372, issn 0931-0509Article
The use of erythropoietin in renal failureMACDOUGALL, I. C; HUTTON, R. D; COLES, G. A et al.Postgraduate medical journal. 1991, Vol 67, Num 783, pp 9-15, issn 0032-5473Article
The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis : results of a phase II studyPROVENZANO, R; BESARAB, A; MACDOUGALL, I. C et al.Clinical nephrology. 2007, Vol 67, Num 5, pp 306-317, issn 0301-0430, 12 p.Article
Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unitMACDOUGALL, I. C; CHANDLER, G; ELSTON, O et al.American journal of kidney diseases. 1999, Vol 34, Num 4, pp S40-S46, issn 0272-6386, SUP2Article
Effects of the correction of renal anaemia by erythropoietin on physiological changes during exerciseLEWIS, N. P; MACDOUGALL, I. C; WILLIS, N et al.European journal of clinical investigation. 1993, Vol 23, Num 7, pp 423-427, issn 0014-2972Article